Clinical Application of 2, 5-DI-O-Acetyl-β-D-Glucaro-(1 →4) (6 → 3)-Dilactone (SLA) to the Bladder Tumor, with Special Reference to its Effect on Frequency of Tumor Recurrences
- 1 October 1972
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 108 (4) , 571-576
- https://doi.org/10.1016/s0022-5347(17)60805-x
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Studies on the Glucaric Acid Pathway in the Metabolism of D-Glucuronic Acid in Mammals. II. Excretion of D-Glucaric Acid in Urine after Administration of Several Monosaccharides and Their Derivatives to MammalsCHEMICAL & PHARMACEUTICAL BULLETIN, 1969
- CLINICAL APPLICATION OF GLUCAROLACTONE TO BLADDER TUMORThe Japanese Journal of Urology, 1968
- Biochemical studies on glucuronic acid and glucaric acidAnalytical Biochemistry, 1965
- ATTEMPTED PROPHYLAXIS OF BLADDER CANCER WITH 1←4 GLUCOSACCHAROLACTONEBritish Journal of Urology, 1964
- THE BIOCHEMISTRY OF CANCER OF THE BLADDERBritish Medical Bulletin, 1958
- Enzyme Activity in Relation to CancerBritish Journal of Cancer, 1957
- Cancer of the Urinary Bladder Induced in Mice with Metabolites of Aromatic Amines and TryptophanBritish Journal of Cancer, 1957
- The metabolism of tryptophan. 2. The metabolism of tryptophan in patients suffering from cancer of the bladderBiochemical Journal, 1956
- The Activity of the Enzymes Sulphatase and β-Glucuronidase in the Urine, Serum and Bladder TissueBritish Journal of Cancer, 1955
- The preparation and properties of β-glucuronidase. 4. Inhibition by sugar acids and their lactonesBiochemical Journal, 1952